Stephen P. Shumack
Fitzroy, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
Digital Skin Checks for Skin Cancer Screening-An Audit of the Triage Performance of DermScreen.
Journal: The Australasian journal of dermatology
Published: November 17, 2025
Practice Guidelines for Teledermatology in Australia: 2025 Update.
Journal: The Australasian journal of dermatology
Published: June 02, 2025
Informing a Position Statement on the Use of Large Language Models and AI Scribes in Dermatology in Australia.
Journal: The Australasian journal of dermatology
Published: May 28, 2025
Radiotherapy-A Renaissance for Skin Cancer.
Journal: The Australasian journal of dermatology
Published: January 06, 2025
Rosacea Core Domain Set for Clinical Trials and Practice: A Consensus Statement.
Journal: JAMA dermatology
Published: April 24, 2024
Cross-sectional burden-of-illness study in atopic dermatitis (MEASURE-AD) in Australia and New Zealand reveals impacts on well-being.
Journal: The Australasian journal of dermatology
Published: March 29, 2024
Minimum labelling requirements for dermatology artificial intelligence-based Software as Medical Device (SaMD): A consensus statement.
Journal: The Australasian journal of dermatology
Published: November 26, 2023
Balancing the risks and benefits of sun exposure: A revised position statement for Australian adults.
Journal: Australian and New Zealand journal of public health
Published: September 03, 2023
The role of micrometastasis in high-risk skin cancers.
Journal: The Australasian journal of dermatology
Published: June 12, 2023
Australian consensus: Treatment goals for moderate to severe psoriasis in the era of targeted therapies - Adult patients.
Journal: The Australasian journal of dermatology
Published: May 11, 2023
The Treat-to-Target Project in Atopic Dermatitis: One Year On.
Journal: Acta dermato-venereologica
Published: December 01, 2022
Risankizumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study.
Journal: Dermatology and therapy
Published: October 14, 2022
Last Updated: 09/26/2026